May 4, 2020 / 12:34 PM / 24 days ago

BRIEF-Marinus Pharmaceuticals Provides Business Update And Reports Q1 2020 Financial Results

May 4 (Reuters) - Marinus Pharmaceuticals Inc:

* MARINUS PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

* MARINUS PHARMACEUTICALS - PIVOTAL PHASE 3 CLINICAL TRIAL FOR STATUS EPILEPTICUS EXPECTED TO BEGIN NEXT QUARTER

* MARINUS PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.32

* MARINUS PHARMACEUTICALS INC - BELIEVES THAT ITS CASH, CASH EQUIVALENTS AS OF MARCH 31, 2020 WILL ENABLE TO FUND CO’S REQUIREMENTS INTO Q3 OF 2021

* MARINUS PHARMACEUTICALS - ON MARCH 31, 2020, HAD CASH AND CASH EQUIVALENTS AND INVESTMENTS TOTALING $77.8 MILLION COMPARED TO $91.7 MILLION ON DEC 31, 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below